Regulation of STARS and Its Downstream Targets Suggest a Novel Pathway Involved in Human Skeletal Muscle Hypertrophy and Atrophy

Overview

Journal J Physiol

Specialty Physiology

Date 2009 Mar 4

PMID 19255118

Citations 51

Authors

Severine Lamon

Marita A Wallace

Bertrand Leger

Aaron P Russell

Affiliations

Soon will be listed here.

Abstract

Skeletal muscle atrophy is a severe consequence of ageing, neurological disorders and chronic disease. Identifying the intracellular signalling pathways controlling changes in skeletal muscle size and function is vital for the future development of potential therapeutic interventions. Striated activator of Rho signalling (STARS), an actin-binding protein, has been implicated in rodent cardiac hypertrophy; however its role in human skeletal muscle has not been determined. This study aimed to establish if STARS, as well as its downstream signalling targets, RhoA, myocardin-related transcription factors A and B (MRTF-A/B) and serum response factor (SRF), were increased and decreased respectively, in human quadriceps muscle biopsies taken after 8 weeks of both hypertrophy-stimulating resistance training and atrophy-stimulating de-training. The mRNA levels of the SRF target genes involved in muscle structure, function and growth, such as alpha-actin, myosin heavy chain IIa (MHCIIa) and insulin-like growth factor-1 (IGF-1), were also measured. Following resistance training, STARS, MRTF-A, MRTF-B, SRF, alpha-actin, MHCIIa and IGF-1 mRNA, as well as RhoA and nuclear SRF protein levels were all significantly increased by between 1.25- and 3.6-fold. Following the de-training period all measured targets, except for RhoA, which remained elevated, returned to base-line. Our results show that the STARS signalling pathway is responsive to changes in skeletal muscle loading and appears to play a role in both human skeletal muscle hypertrophy and atrophy.

Citing Articles

In Vitro Gene Therapy Using Human iPS-Derived Mesoangioblast-Like Cells (HIDEMs) Combined with Microdystrophin () Expression as the New Strategy for Duchenne Muscular Dystrophy (DMD) Experimental Treatment.

Budzinska M, Malcher A, Zimna A, Kurpisz M Int J Mol Sci. 2024; 25(22).

PMID: 39595938 PMC: 11593506. DOI: 10.3390/ijms252211869.

Network model of skeletal muscle cell signalling predicts differential responses to endurance and resistance exercise training.

Fowler A, Knaus K, Khuu S, Khalilimeybodi A, Schenk S, Ward S Exp Physiol. 2024; 109(6):939-955.

PMID: 38643471 PMC: 11140181. DOI: 10.1113/EP091712.

Potential risk factors and genetic variants associated with dental caries incidence in Appalachia using genome-wide survival analysis.

Zou T, Neiswanger K, Feingold E, Foxman B, McNeil D, Marazita M Int J Mol Epidemiol Genet. 2023; 14(2):19-33.

PMID: 37736056 PMC: 10509536.

RSPO3 is a novel contraction-inducible factor identified in an "in vitro exercise model" using primary human myotubes.

Takahashi T, Li Y, Chen W, Nyasha M, Ogawa K, Suzuki K Sci Rep. 2022; 12(1):14291.

PMID: 35995979 PMC: 9395423. DOI: 10.1038/s41598-022-18190-z.

Non-coding RNA basis of muscle atrophy.

Liu Q, Deng J, Qiu Y, Gao J, Li J, Guan L Mol Ther Nucleic Acids. 2021; 26:1066-1078.

PMID: 34786211 PMC: 8569427. DOI: 10.1016/j.omtn.2021.10.010.

References

Sakuma K, Akiho M, Nakashima H, Akima H, Yasuhara M . Age-related reductions in expression of serum response factor and myocardin-related transcription factor A in mouse skeletal muscles. Biochim Biophys Acta. 2008; 1782(7-8):453-61. DOI: 10.1016/j.bbadis.2008.03.008. View

Charvet C, Houbron C, Parlakian A, Giordani J, Lahoute C, Bertrand A . New role for serum response factor in postnatal skeletal muscle growth and regeneration via the interleukin 4 and insulin-like growth factor 1 pathways. Mol Cell Biol. 2006; 26(17):6664-74. PMC: 1592825. DOI: 10.1128/MCB.00138-06. View

Schiaffino S, Sandri M, Murgia M . Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda). 2007; 22:269-78. DOI: 10.1152/physiol.00009.2007. View

Sakuma K, Nishikawa J, Nakao R, Nakano H, Sano M, Yasuhara M . Serum response factor plays an important role in the mechanically overloaded plantaris muscle of rats. Histochem Cell Biol. 2003; 119(2):149-60. DOI: 10.1007/s00418-003-0499-2. View

Jagoe R, Lecker S, Gomes M, Goldberg A . Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. FASEB J. 2002; 16(13):1697-712. DOI: 10.1096/fj.02-0312com. View

Campos G, Luecke T, Wendeln H, Toma K, Hagerman F, Murray T . Muscular adaptations in response to three different resistance-training regimens: specificity of repetition maximum training zones. Eur J Appl Physiol. 2002; 88(1-2):50-60. DOI: 10.1007/s00421-002-0681-6. View

Baldi J, Jackson R, Moraille R, Mysiw W . Muscle atrophy is prevented in patients with acute spinal cord injury using functional electrical stimulation. Spinal Cord. 1998; 36(7):463-9. DOI: 10.1038/sj.sc.3100679. View

Fluck M, Carson J, Schwartz R, Booth F . SRF protein is upregulated during stretch-induced hypertrophy of rooster ALD muscle. J Appl Physiol (1985). 1999; 86(6):1793-9. DOI: 10.1152/jappl.1999.86.6.1793. View

Woelfle J, Rotwein P . In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. Am J Physiol Endocrinol Metab. 2004; 286(3):E393-401. DOI: 10.1152/ajpendo.00389.2003. View

10.

Vergani L, Malena A, Sabatelli P, Loro E, Cavallini L, Magalhaes P . Cultured muscle cells display defects of mitochondrial myopathy ameliorated by anti-oxidants. Brain. 2007; 130(Pt 10):2715-24. DOI: 10.1093/brain/awm151. View

11.

McClung J, Lee W, Thompson R, Lowe L, Carson J . RhoA induction by functional overload and nandrolone decanoate administration in rat skeletal muscle. Pflugers Arch. 2003; 447(3):345-55. DOI: 10.1007/s00424-003-1151-7. View

12.

Miano J, Long X, Fujiwara K . Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol. 2006; 292(1):C70-81. DOI: 10.1152/ajpcell.00386.2006. View

13.

Arai A, Spencer J, Olson E . STARS, a striated muscle activator of Rho signaling and serum response factor-dependent transcription. J Biol Chem. 2002; 277(27):24453-9. DOI: 10.1074/jbc.M202216200. View

14.

Wang D, Li S, Hockemeyer D, Sutherland L, Wang Z, Schratt G . Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci U S A. 2002; 99(23):14855-60. PMC: 137508. DOI: 10.1073/pnas.222561499. View

15.

Liu H, Halayko A, Fernandes D, Harmon G, McCauley J, Kocieniewski P . The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. Am J Respir Cell Mol Biol. 2003; 29(1):39-47. DOI: 10.1165/rcmb.2002-0206OC. View

16.

Fluck M, Waxham M, Hamilton M, Booth F . Skeletal muscle Ca(2+)-independent kinase activity increases during either hypertrophy or running. J Appl Physiol (1985). 2000; 88(1):352-8. DOI: 10.1152/jappl.2000.88.1.352. View

17.

Leger B, Vergani L, Soraru G, Hespel P, Derave W, Gobelet C . Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J. 2006; 20(3):583-5. DOI: 10.1096/fj.05-5249fje. View

18.

Mahadeva H, Brooks G, Lodwick D, Chong N, Samani N . ms1, a novel stress-responsive, muscle-specific gene that is up-regulated in the early stages of pressure overload-induced left ventricular hypertrophy. FEBS Lett. 2002; 521(1-3):100-4. DOI: 10.1016/s0014-5793(02)02833-8. View

19.

Anderson T, Kearney J . Effects of three resistance training programs on muscular strength and absolute and relative endurance. Res Q Exerc Sport. 1982; 53(1):1-7. DOI: 10.1080/02701367.1982.10605218. View

20.

Cai D, Frantz J, Tawa Jr N, Melendez P, Oh B, Lidov H . IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell. 2004; 119(2):285-98. DOI: 10.1016/j.cell.2004.09.027. View